Back

Pinealon is a short synthetic tripeptide from the same Russian research group behind Epitalon and Semax, studied for neuroprotective and cellular-aging effects. Its proposed mechanism (direct gene-expression regulation rather than receptor binding) is a hypothesis largely specific to its originating research group and has not been independently replicated at scale.

Not FDA-approved; sold for research use only.

🇺🇸USA
NextGenPepsTop pick

United States

COA / lab reports
$73.00
Shop with discount →

Evidence base — read this first

Part of a family of short synthetic peptides (2-4 amino acids) developed by Vladimir Khavinson's research group, each targeted at a specific tissue/organ. The evidence base for this entire peptide family shares the same limitation: it's concentrated almost entirely within this one research lineage (largely the same institute, often the same handful of authors), is mostly preclinical (rodent, cell-culture) or small Russian human pilot work, and hasn't been independently replicated by unaffiliated Western labs in a way this research pass could verify. None of these compounds is FDA or EMA approved for human use anywhere.

Benefits

Pinealon (Glu-Asp-Arg) is pitched as a neuroprotective/pineal-related peptide. Secondary reporting describes a PubMed-indexed study finding dose-dependent reduction of oxidative-stress-induced ROS accumulation in cultured cells, and a separate human study on synthetic peptides in elderly patients with chronic polymorbidity and organic brain syndrome. PMID 26390612 — this specific citation wasn't independently re-verified against the primary source (title/findings) in this research pass; treat with the same lower-confidence tier as other unverified citations in this batch until confirmed directly.

Frequently asked questions

What is Pinealon researched for?+

Neuroprotection, cognitive support, and cellular aging, primarily in the same body of Russian peptide-bioregulator research that produced Epitalon and Semax.

How does Pinealon supposedly work?+

Its originating research group proposes it can cross cell and nuclear membranes to directly regulate gene expression, unlike most peptides which act via surface receptors — a hypothesis that remains largely confined to that research group's own publications.

Is Pinealon FDA-approved?+

No, it is not an approved drug and is sold for research use only.

Is there real research behind it, or is this fringe?+

There's a genuinely large body of it — over four decades and 700+ publications from the group behind it — but nearly all of it originates from Russian institutions, with limited independent replication elsewhere. Not fringe exactly, but not validated the way most Western-approved compounds are either.

What's the actual evidence for it working?+

Mostly animal studies — aged rats given Pinealon showed measurably better performance on maze-based learning and memory tasks. Real and specific, just not the same as human clinical trial data.

How does it relate to Epitalon?+

Same research family, same short-chain-peptide-as-tissue-regulator concept, different target — Epitalon is framed around general longevity and pineal hormone regulation broadly, Pinealon specifically around brain and cognitive tissue.

Looking for something specific, or placing a wholesale order? Send us a DM or email.